您好,欢迎访问山东省农业科学院文献资源数据库平台

Design and synthesis of pregnenolone/2-cyanoacryloyl conjugates with dual NF-kappa B inhibitory and anti-proliferative activities

文献类型: 外文期刊

作者: Song, Jia-Li 1 ; Zhang, Juan 2 ; Liu, Chang-Liang 4 ; Liu, Chao; Zhu, Kong-Kai 1 ; Yang, Fei-Fei 1 ; Liu, Xi-Gong 1 ; Longo, Joao Paulo Figueiro 2 ; Muehlmann, Luis Alexandre 2 ; Azevedo, Ricardo Bentes 3 ; Zhang, Yu-Ying 1 ; Guo, Yue-Wei; Jiang, Cheng-Shi 1 ; Zhang, Hua 1 ;

作者机构: 1.Univ Jinan, Sch Biol Sci & Technol, Jinan 250022, Shandong, Peoples R China

2.Univ Brasilia, Fac Ceilandia, BR-72220275 Brasilia, DF, Brazil

3.Univ Brasilia, Inst Biol Sci, BR-70910900 Brasilia, DF, Brazil

4.Harvard Med Sch, Dept Neurobiol, Bost

关键词: Pregnenolone; NF-kappa B; 2-Cyanoacryloyl; Michael acceptor; Anti-proliferative activity

期刊名称:BIOORGANIC & MEDICINAL CHEMISTRY LETTERS ( 影响因子:2.823; 五年影响因子:2.677 )

ISSN: 0960-894X

年卷期: 2017 年 27 卷 20 期

页码:

收录情况: SCI

摘要: Twenty-five novel pregnenolone/2-cyanoacryloyl conjugates (6-30) were designed and prepared, with the aim of developing novel anticancer drugs with dual NF-kappa B inhibitory and anti-proliferative activities. Compounds 22 and 27-30 showed inhibition against TNF-alpha-induced NF-kappa B activation in luciferase assay, which was confirmed by Western blotting. Among them, compound 30 showed potent NF-kappa B inhibitory activity (IC50 = 2.5 mu M) and anti-proliferative against MCF-7, A549, H157, and HL-60 cell lines (IC50 = 6.5-36.2 mu M). The present study indicated that pregnenolone/2-cyanoacryloyl conjugate I can server as a novel scaffold for developing NF-kappa B inhibitors and anti-proliferative agents in cancer chemotherapy. (C) 2017 Elsevier Ltd. All rights reserved.

  • 相关文献
作者其他论文 更多>>